أعرض في EDS

1349P Lorlatinib for advanced ROS1+ non-small cell lung cancer (NSCLC): Efficacy and safety data from IFCT-1803 LORLATU expanded access program (EAP) cohort

التفاصيل البيبلوغرافية
العنوان: 1349P Lorlatinib for advanced ROS1+ non-small cell lung cancer (NSCLC): Efficacy and safety data from IFCT-1803 LORLATU expanded access program (EAP) cohort
المؤلفون: J. Tillon, V. Avrillon, Jaafar Bennouna, Gérard Zalcman, D. Moro-Sibilot, L. Odier, Charles Ricordel, M. Coudurier, S. Galland Girodet, R. Lamy, B. Roch, Benjamin Besse, P. Missy, Virginie Westeel, T. Egenod, J. Otto, Simon Baldacci, Nicolas Girard, Michael Duruisseaux, Jacques Cadranel
المصدر: Annals of Oncology. 31:S865
بيانات النشر: Elsevier BV, 2020.
سنة النشر: 2020
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, non-small cell lung cancer (NSCLC), Hematology, medicine.disease, Lorlatinib, Internal medicine, Expanded access, Cohort, medicine, ROS1, business
تدمد: 0923-7534
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4341470997408587c8c07bfc0d3f5420
https://doi.org/10.1016/j.annonc.2020.08.1663
حقوق: OPEN
رقم الأكسشن: edsair.doi...........4341470997408587c8c07bfc0d3f5420
قاعدة البيانات: OpenAIRE
الوصف
تدمد:09237534